Work

1377P Preliminary efficacy and safety results of KN026 (a HER2-targeted bispecific antibody) in combination with KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in patients (pts) with HER2-positive gastrointestinal tumors

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.1486

Authors: J. Gong, L. Shen, S. Luo, Z. Dong, D. Liu, S. An, J. Xu, J. Yang, Y. Qi, J. Men, L. Kong, Y. Yang, T. Xu

Institutions: Peking University Cancer Hospital, Henan Cancer Hospital, Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (China)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3203083241

FWCI: 0.641

Cites:

Cited by: 8

Related to: 10